Pharmaceutical Technology
April 02, 2009
News
33
4
Although industry is tightening its belt, contract manufacturers across Europe are actually making out quite well by taking on additional projects and new roles.
April 02, 2009
In the Spotlight
33
4
Editors' Picks of Pharmaceutical Science & Technology Innovations
April 02, 2009
Peer-Reviewed Research
33
4
The authors describe a novel analytical approach that uses the shape-analysis capabilities of MFI to detect and enumerate silicone oil microdroplets in protein formulations that also contain aggregates of similar size and in a similar concentration.
April 02, 2009
Peer-Reviewed Research
33
4
The author reviews the types of reference-standard materials used in drug-product manufacturing, discusses current regulatory requirements, and outlines a reference-standard qualification program.
April 02, 2009
Online Exclusive
33
4
In a recent book, UK regulators explain how to establish a pharmacovigilance system.
April 02, 2009
Washington Report
33
4
FDA is poised to gain authority and resources to ensure the quality of food and drugs.
April 02, 2009
Special Report
33
4
By reducing cycle time and implementing quality-by-design inspired engineering, advanced lyophilization systems are driving the industry toward greater efficiency and control.
April 02, 2009
Insider Solutions
33
4
Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.
April 02, 2009
From The Editor
33
4
Obama's cost-containment and science-innovation initiatives need to overlap.
April 02, 2009
Ingredients Insider
33
4
A review of recent product innovations, policy developments, and growth prospects in the excipients market.
April 02, 2009
Online Exclusive
33
4
President Obama's economic recovery plain includes goals such as reducing the number of uninsured citizens and improving the quality of healthcare.
April 02, 2009
Peer-Reviewed Research
33
4
A Position Paper from the AAPS In Vitro Release and Dissolution Focus Group
April 02, 2009
PharmTech Talk
33
4
The financial and economic downturn is likey to have long-term implications for outsourcing.
April 02, 2009
Viewpoint
33
4
The role of automation suppliers is transforming to meet the pharma industry's demand for change.
April 02, 2009
Agent-In-Place
33
4
GMP agents report on old products, aseptic violations, and unexpected emotions.
April 02, 2009
Outsourcing Outlook
33
4
Despite the market downturn, private equity investors are lining up for pharmaceutical services.